078b002649143aa3ff0dd239166ea031de491b020a18454ffc5d8bdad7ce01bf

Net sales (USD, thousands)

Cost of sales (USD, thousands)

Cost of sales (exclusive of amortization of intangibles) (USD, thousands)

Gross profit (USD, thousands)

Research and development (USD, thousands)

Selling, general and administrative (USD, thousands)

Provision for litigation, net (USD, thousands)

Amortization of intangibles (USD, thousands)

Acquisition-related costs (USD, thousands)

Restructuring costs (USD, thousands)

Total operating expenses (USD, thousands)

Operating income/(loss) (USD, thousands)

Interest income/(expense), net (USD, thousands)

Foreign currency transaction gain/(loss) (USD, thousands)

Other income/(expense) (USD, thousands)

Total other income/(expense), net (USD, thousands)

Income/(loss) before income taxes (USD, thousands)

Income tax provision/(benefit) (USD, thousands)

Net income/(loss) (USD, thousands)

Unrealized gain/(loss) on marketable securities (USD, thousands)

Foreign currency translation gain/(loss) (USD, thousands)

Total other comprehensive income/(loss), net of tax (USD, thousands)

Comprehensive income/(loss) (USD, thousands)

Earnings per share: Basic (USD)

Earnings per share: Diluted (USD)

Weighted average shares outstanding: Basic (thousands)

Weighted average shares outstanding: Diluted (thousands)

0de675784f9aaaacda559d7b7b253de698eef5aa3dc2a6c8fbedbabc82b02ee6

70a26d40622af585aceb0b334ab4547a00ed706ad913d459a84b7ee64c6cab97

Number of countries in which products and services are sold (countries)

104f864ab9f893582a1724ffb1cbef134a6d1730d66b45af3c2269d6db27bfc5

Current Assets (USD, thousands)

Cash and Cash Equivalents (USD, thousands)

Accounts Receivable (USD, thousands)

Inventory (USD, thousands)

Non-Current Assets (USD, thousands)

Property, Plant, and Equipment (PP&E) (USD, thousands)

Goodwill (USD, thousands)

Intangible Assets (USD, thousands)

Current Liabilities (USD, thousands)

Accounts Payable (USD, thousands)

Short-term Debt (USD, thousands)

Accrued Expenses (USD, thousands)

Non-Current Liabilities (USD, thousands)

Long-term Debt (USD, thousands)

Lease Liabilities (USD, thousands)

Deferred Tax Liabilities (USD, thousands)

Shareholders' Equity (USD, thousands)

Retained Earnings (USD, thousands)

Common Stock (USD, thousands)

Additional Paid-in Capital (USD, thousands)

f4a1f38da9bffedafe7c23095f09c207d60c43e90c60e703e0d462fdb50de33e

United States

International

- Europe and Middle East

- Latin America

- Asia Pacific

- Other International

Total Revenue

96e1dfbee37c3cbd32d8a97eba107ea01e4c7d222fad4e0d3d43752703188f78

Total Revenue (USD, thousands)

Cost of Goods Sold (COGS) (USD, thousands)

Selling, General, and Administrative Expenses (SG&A) (USD, thousands)

Research and Development (R&D) (USD, thousands)

Depreciation and Amortization (D&A) (USD, thousands)

Interest Expense (USD, thousands)

Operating Income (EBIT) (USD, thousands)

Net Income (USD, thousands)

Earnings Per Share (EPS) - Basic (USD)

Earnings Per Share (EPS) - Diluted (USD)

a8f38a59a511abe1c1b3e24f58c372a91f46c0a5526117f65a99bcdfaa7b853f

Adjustments for Non-Cash Items (USD, thousands)

Stock-Based Compensation (USD, thousands)

Changes in Working Capital (USD, thousands)

Capital Expenditures (CapEx) (USD, thousands)

Proceeds from / Repayments of Debt (USD, thousands)

Share Repurchases (USD, thousands)

Dividend Payments (USD, thousands)

Net Change in Cash (USD, thousands)

1a9cae48061f32cff5c106538dbe8c1d0e9b978ece34e60d153d9bfae832ca4f

GLOBUS MEDICAL (GMED)

Financials